4//SEC Filing
REY-GIRAUD AGNES 4
Accession 0000899243-21-036346
CIK 0001809519other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 7:53 PM ET
Size
21.9 KB
Accession
0000899243-21-036346
Insider Transaction Report
Form 4
REY-GIRAUD AGNES
Director
Transactions
- Sale
Class A Common Stock
2021-09-14$45.00/sh−14,454$650,462→ 0 total(indirect: By Trust) - Sale
Class A Common Stock
2021-09-15$45.03/sh−4,637$208,796→ 0 total(indirect: By Trust) - Conversion
Class B Common Stock
2021-09-16−5,909→ 255,000 total(indirect: By Trust)→ Class A Common Stock (5,909 underlying) - Conversion
Class A Common Stock
2021-09-16+5,909→ 5,909 total(indirect: By Trust) - Conversion
Class B Common Stock
2021-09-14−14,454→ 265,546 total(indirect: By Trust)→ Class A Common Stock (14,454 underlying) - Conversion
Class B Common Stock
2021-09-15−4,637→ 260,909 total(indirect: By Trust)→ Class A Common Stock (4,637 underlying) - Conversion
Class A Common Stock
2021-09-14+14,454→ 14,454 total(indirect: By Trust) - Conversion
Class A Common Stock
2021-09-15+4,637→ 4,637 total(indirect: By Trust) - Sale
Class A Common Stock
2021-09-16$45.01/sh−5,909$265,936→ 0 total(indirect: By Trust)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.05, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.22, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.05, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027.
Documents
Issuer
GoodRx Holdings, Inc.
CIK 0001809519
Entity typeother
Related Parties
1- filerCIK 0001235685
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 7:53 PM ET
- Size
- 21.9 KB